The bill, proposed by Governor Martin O’Malley, would have given state officials and other whistle-blowers more latitude in pursuing Medicaid fraud cases and collecting damages.
Many doctors, hospitals and professionals from the pharmaceutical industry opposed the bill, saying that it would lead to unnecessary lawsuits and add to administrative costs for healthcare providers, according to the report.
Read the Baltimore Sun’s report about Maryland’s failed Medicaid fraud bill.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.